Antibiotice S.A. (BVB:ATB)
Romania · Delayed Price · Currency is RON 1.940
+0.004 (0.21%)
At close: Sep 2, 2026
Antibiotice Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 610.66 | 645.28 | 675.01 | 614.16 | 483.72 | 366.21 |
Other Revenue | 5.92 | 1.98 | 2.57 | 1.12 | 7.5 | 2.07 |
| 616.58 | 647.25 | 677.58 | 615.29 | 491.22 | 368.28 | |
Revenue Growth | -6.43% | -4.48% | 10.12% | 25.26% | 33.38% | 8.04% |
Cost of Revenue | 262.91 | 259.54 | 254.42 | 232.64 | 187.45 | 146.97 |
Gross Profit | 353.67 | 387.72 | 423.16 | 382.65 | 303.77 | 221.31 |
Selling, General & Admin | 207.24 | 204.62 | 198.64 | 161.69 | 130.53 | 125.92 |
Other Operating Expenses | 64.3 | 59.33 | 72.28 | 95.66 | 78.16 | 37.02 |
Operating Expenses | 327.25 | 316.94 | 315.98 | 285.23 | 230.95 | 187.06 |
Operating Income | 26.43 | 70.77 | 107.19 | 97.42 | 72.81 | 34.25 |
Interest Expense | -5.07 | -4.47 | -4.54 | -4.15 | -3.59 | -3.52 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -9.42 | -6.42 | 0.26 | -0.95 | -0.8 | -0.22 |
Other Non Operating Income (Expenses) | 0.21 | 0.21 | 0.04 | 0.08 | -0.18 | -0.21 |
EBT Excluding Unusual Items | 12.15 | 60.09 | 102.95 | 92.42 | 68.25 | 30.3 |
Gain (Loss) on Sale of Assets | 0.05 | 0.05 | 0.16 | 0 | 0.1 | - |
Asset Writedown | - | - | - | -0.9 | -3.04 | - |
Pretax Income | 12.2 | 60.15 | 103.11 | 91.52 | 65.31 | 30.3 |
Income Tax Expense | 4.07 | 8.38 | 0.91 | 10.44 | 13.84 | 0.36 |
Net Income | 8.13 | 51.77 | 102.2 | 81.09 | 51.47 | 29.94 |
Net Income to Common | 8.13 | 51.77 | 102.2 | 81.09 | 51.47 | 29.94 |
Net Income Growth | -90.67% | -49.35% | 26.04% | 57.54% | 71.92% | 13.46% |
Shares Outstanding (Basic) | 671 | 671 | 671 | 671 | 671 | 671 |
Shares Outstanding (Diluted) | 671 | 671 | 671 | 671 | 671 | 671 |
Shares Change | -0.03% | - | - | - | - | - |
EPS (Basic) | 0.01 | 0.08 | 0.15 | 0.12 | 0.08 | 0.04 |
EPS (Diluted) | 0.01 | 0.08 | 0.15 | 0.12 | 0.08 | 0.04 |
EPS Growth | -90.66% | -49.35% | 26.04% | 57.54% | 71.92% | 13.46% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -97.64 | -70.17 | -3.63 | 39.43 | 78.09 | 15.39 |
Free Cash Flow Per Share | -0.15 | -0.10 | -0.01 | 0.06 | 0.12 | 0.02 |
Dividend Per Share | 0.036 | 0.036 | 0.021 | 0.083 | 0.008 | 0.003 |
Dividend Growth | 74.05% | 74.05% | -75.21% | 946.74% | 147.72% | -3.27% |
Gross Margin | 57.36% | 59.90% | 62.45% | 62.19% | 61.84% | 60.09% |
Operating Margin | 4.29% | 10.94% | 15.82% | 15.83% | 14.82% | 9.30% |
Profit Margin | 1.32% | 8.00% | 15.08% | 13.18% | 10.48% | 8.13% |
Free Cash Flow Margin | -15.83% | -10.84% | -0.53% | 6.41% | 15.90% | 4.18% |
EBITDA | 83.34 | 124.98 | 152.24 | 125.35 | 95.38 | 58.68 |
EBITDA Margin | 13.52% | 19.31% | 22.47% | 20.37% | 19.42% | 15.93% |
D&A For EBITDA | 56.92 | 54.2 | 45.06 | 27.93 | 22.57 | 24.43 |
EBIT | 26.43 | 70.77 | 107.19 | 97.42 | 72.81 | 34.25 |
EBIT Margin | 4.29% | 10.94% | 15.82% | 15.83% | 14.82% | 9.30% |
Effective Tax Rate | 33.34% | 13.93% | 0.88% | 11.40% | 21.19% | 1.20% |
Advertising Expenses | - | 22.63 | 27.51 | - | - | 11.01 |